Por: WPTV Crime May 20, 2023
RIVIERA BEACH, Fla. — A man and woman are being held without bond in a shooting linked to a drug deal that left a woman identified as the dealer paralyzed from the neck down, Riviera Beach police said. Jeff Ringrose/WPTV Christopher Laray Lane Jr., of Lake Park, at first appearance. Christopher Laray Lane Jr., of Lake Park, and Jazzmain Bush, of Palm Beach Gardens, both 23, and face charges of attempted second-degree murder with a firearm,... + full article
Newsweek USA Nation March 21, 2023
The U.S. Drug Enforcement Administration (DEA) warned that there has been a sharp uptick in the amount of fentanyl containing a powerful tranquilizer that may lead to amputation and increases the chance of death for users of the drug.According to a release on Monday, the DEA has... + más
Colorado Senate nominee O'Dea dropped out of college to start working. Can he beat a 13-year incumbent? | Fox News
US Federal Drug Agents Seize Enough Fentanyl In 2022 That Can Potentially Kill Every American | RTTNews
The New York Times USA Health March 08, 2023
The company that makes Makena, the only drug aimed at preventing preterm birth, announced on Tuesday that it was voluntarily pulling the medication off the market after advisers for the Food and Drug Administration concluded that the treatment did not help pregnant women at... + más
US gets D+ grade for rising preterm birth rates, new report finds | CNN
FDA panel recommends pulling preterm birth drug from the market | The Boston Globe
ABC News USA Health March 08, 2023
WASHINGTON -- The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S., after regulators signaled plans to follow through on a long-delayed effort to force it from the market.The drug, Makena, is a synthetic... + más
FDA holds hearing to remove pregnancy drug from market, company pushes back | WGN-TV
Maker of unproven birth drug Makena to pull from US market | Associated Press
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
The New York Times USA Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
CNBC USA Health September 29, 2022
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
About iurex | Privacy Policy | Disclaimer |